Latest News

STAT Plus: Former Biogen sales rep, who says she was fired for complaining about off-label marketing, is awarded $6 million

A federal jury in Seattle has awarded nearly $6 million to a former Biogen (BIIB) sales rep who claimed she was fired after complaining about being pressured to pursue off-label marketing for a multiple sclerosis treatment.

In her lawsuit, Danita Erickson contended that, in the fall of 2017, Biogen sought to ensure that Zinbryta was prescribed by a hematologist for a patient with aplastic anemia — a condition in which the body does not produce enough blood cells — and who was also on Medicare. However, the medicine was only approved for treating relapsing multiple sclerosis patients.

Continue to STAT Plus to read the full story…

Source link

Related posts

Medical News Today: How to reduce food waste


Surge in US measles cases leads to extraordinary measures


CES 2020: YO At-Home Sperm Testing with Your Smartphone


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World